Malignant versus benign hepatic masses in patients with recurrent pyogenic cholangitis: MR differential diagnosis
- Authors
- Eun, Hyo Won; Kim, Jung Hoon; Hong, Seong Sook; Kim, Young Jae
- Issue Date
- Oct-2012
- Publisher
- Springer New York
- Keywords
- Biliary system; Pyogenic cholangitis; Cancer; Cholangiocarcinoma; Abscess; MRI
- Citation
- Abdominal Imaging, v.37, no.5, pp 767 - 774
- Pages
- 8
- Journal Title
- Abdominal Imaging
- Volume
- 37
- Number
- 5
- Start Page
- 767
- End Page
- 774
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14827
- DOI
- 10.1007/s00261-011-9833-7
- ISSN
- 0942-8925
1432-0509
- Abstract
- To assess MR findings and diagnostic performance for differentiating malignant from benign hepatic masses in recurrent pyogenic cholangitis (RPC). During a recent 6-year period, we performed MRI in 352 patients with RPC. Among them, 58 had confirmed hepatic masses; cholangiocarcinoma (n = 15), abscess (n = 37), inflammatory pseudotumor (n = 3), biloma (n = 3). Two radiologists assessed MR findings including enhancement patterns, intratumoral appearance, peritumoral changes, mass location, and multiplicity. They also graded the malignancy using common MR findings. The receiver operating characteristic analysis and Chi-square test were used. The kappa statistics was used to determine interobserver agreement. The common findings for cholangiocarcinoma were thin and lobulated enhancement at the periphery (n = 8, 53%, P < 0.05); ill-defined enhancement (n = 7, 47%, P < 0.05); slightly high signal on T2 (n = 13, 87%, P < 0.05); mass located in the same lobe of atrophy (n = 11, 73%, P < 0.05) and portal vein thrombosis (n = 15, 100%, P < 0.05). The common findings for benign mass were target-like enhancement (n = 36, 84%, P < 0.05); cluster appearance (n = 15, 35%, P < 0.05); central, fluid-like space (n = 29, 67%, P < 0.05); peritumoral regional high signal on T2 (n = 32, 74%, P < 0.05); multiplicity(n = 21, 49%, P < 0.05). Interobserver agreement was excellent (kappa = 0.81-1.000). Area under the curve (Az) for differentiating malignant masses was 0.989, sensitivity was 95.3%, and specificity was 95.3%. There was good interobserver agreement (kappa = 0.74). MR imaging is very useful for differential diagnosis of malignant vs. benign hepatic masses in patients with RPC.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Radiology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.